Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 8, 2007 - Issue 8
Submit an article Journal homepage
161
Views
9
CrossRef citations to date
0
Altmetric
Review

Health economic review of recombinant activated factor VII for treatment of bleeding episodes in hemophilia patients with inhibitors

Jennifer M Stephens Clinical Director, Pharmerit North America LLC, 7272 Wisconsin Ave, Suite 300, Bethesda, MD 20814-4858, USA. [email protected]
,
Ashish V Joshi Senior Manager, Health Economics and Market Access Strategy, Novo Nordisk Inc., 100 College Road West, Princeton, NJ 08540, USA. [email protected]
,
Michael Sumner Executive Director, Medical Affairs, Novo Nordisk Inc., 100 College Road West, Princeton, NJ 08540, USA. [email protected]
&
Marc F Botteman Director of Health Economics, Pharmerit North America LLC, 7272 Wisconsin Ave, Suite 300, Bethesda, MD 20814-4858, USA. [email protected]
Pages 1127-1136 | Published online: 22 May 2007

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Joel W. Hay & Zheng-Yi Zhou. (2011) Systematic literature review of economics analysis on treatment of mild-to-moderate bleeds with aPCC versus rFVIIa. Journal of Medical Economics 14:4, pages 516-525.
Read now

Articles from other publishers (8)

Maria del Carmen Rodríguez-Zepeda, Lourdes González, Amalia Bravo, Teresa Pompa, Salvador Silva, Rogelio Paredes, Jaime García, Mafalda Ramos, Lars Wilkinson & Mark Lamotte. (2018) Cost-Effectiveness of rFVIIa versus pd-aPCC in the Management of Mild to Moderate Bleeds in Pediatric Patients with Hemophilia A with Inhibitors in Mexico. Value in Health Regional Issues 17, pages 164-173.
Crossref
J. J. van Veen, R. M. Maclean, K. K. Hampton, A. Hamer & M. Makris. (2014) Major surgery in severe haemophilia A with inhibitors using a recombinant factor VIIa and activated prothrombin complex concentrate hybrid regimen. Haemophilia 20:4, pages 587-592.
Crossref
V. Jimenez-Yuste, R. Núñez, J. A. Romero, B. Montoro & B. Espinós. (2013) Cost-effectiveness of recombinant activated factor VII vs. plasma-derived activated prothrombin complex concentrate in the treatment of mild-to-moderate bleeding episodes in patients with severe haemophilia A and inhibitors in Spain. Haemophilia 19:6, pages 841-846.
Crossref
Peter Salaj, Miroslav Penka, Petr Smejkal, Vera Geierova, Petra Ovesná, Petr Brabec, Petr Cetkovsky, Radovan Kubes, Johan Mesterton & Peter Lindgren. (2012) Economic analysis of recombinant activated factor VII versus plasma-derived activated prothrombin complex concentrate in mild to moderate bleeds: Haemophilia registry data from the Czech Republic. Thrombosis Research 129:5, pages e233-e237.
Crossref
Nathaniel McQuay, James Cipolla, Eleanor Z. Franges & Gregory E. Thompson. (2009) The use of recombinant activated factor VIIa in coagulopathic traumatic brain injuries requiring emergent craniotomy: is it beneficial?. Journal of Neurosurgery 111:4, pages 666-671.
Crossref
L. SCALONE, L. G. MANTOVANI, F. BORGHETTI, S. VON MACKENSEN & A. GRINGERI. (2009) Patients’, physicians’, and pharmacists’ preferences towards coagulation factor concentrates to treat haemophilia with inhibitors: results from the COHIBA Study. Haemophilia 15:2, pages 473-486.
Crossref
C. W. YOU, S. Y. LEE & S. K. PARK. (2009) Cost and effectiveness of treatments for mild-to-moderate bleeding episodes in haemophilia patients with inhibitors in Korea. Haemophilia 15:1, pages 217-226.
Crossref
Luciana Scalone. (2008) Investing in Hemophilia Care: Benefits and Costs for Patients and Society. Seminars in Hematology 45, pages S31-S34.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.